Raymond de Vre
Chairman presso PolyPeptide Laboratories A/S
Patrimonio netto: 554 597 $ in data 31/03/2024
Profilo
Raymond de Vre is currently the Chairman at PolyPeptide Laboratories A and a Director at Aurigene Discovery Technologies Ltd.
He was previously the Chief Executive Officer at PolyPeptide Group AG from 2021 to 2023 and a Partner at McKinsey & Co., Inc. from 2004 to 2011.
Dr. de Vre holds a doctorate degree from Stanford University and a graduate degree from Université Libre de Bruxelles.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
POLYPEPTIDE GROUP AG
0.05% | 31/12/2022 | 16 486 ( 0.05% ) | 554 597 $ | 31/03/2024 |
Posizioni attive di Raymond de Vre
Società | Posizione | Inizio |
---|---|---|
Aurigene Discovery Technologies Ltd.
Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. | Director/Board Member | - |
PolyPeptide Laboratories A/S
PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries PolyPeptide Laboratories A/S manufactures polypeptides and custom peptide synthesis. It offers custom research grade, good manufacturing practice-grade, therapeutic, generic and radiolabeled peptides. The company was founded in 2004 and is headquartered in Hillerod, Denmark. | Chairman | - |
Precedenti posizioni note di Raymond de Vre
Società | Posizione | Fine |
---|---|---|
POLYPEPTIDE GROUP AG | Chief Executive Officer | 30/01/2023 |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2011 |
Formazione di Raymond de Vre
Stanford University | Doctorate Degree |
Université Libre de Bruxelles | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
POLYPEPTIDE GROUP AG | Health Technology |
Aziende private | 3 |
---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Aurigene Discovery Technologies Ltd.
Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. | Health Technology |
PolyPeptide Laboratories A/S
PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries PolyPeptide Laboratories A/S manufactures polypeptides and custom peptide synthesis. It offers custom research grade, good manufacturing practice-grade, therapeutic, generic and radiolabeled peptides. The company was founded in 2004 and is headquartered in Hillerod, Denmark. | Process Industries |
- Borsa valori
- Insiders
- Raymond de Vre